You are here

Polar sampling and optimization of protein-ligand cocrystal structures

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41GM116300-01A1
Agency Tracking Number: R41GM116300
Amount: $224,934.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NIGMS
Solicitation Number: PA15-270
Timeline
Solicitation Year: 2016
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-06-06
Award End Date (Contract End Date): 2018-05-31
Small Business Information
3805 OLD EASTON ROAD
Doylestown, PA 18902-8400
United States
DUNS: 078286662
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 CHARLES REYNOLDS
 (215) 358-2028
 creynolds@ansarisbio.com
Business Contact
 CHARLES REYNOLDS
Phone: (215) 353-2089
Email: creynolds@gfreebio.com
Research Institution
N/A
Abstract

DESCRIPTION provided by applicant Gfree Bio proposes to collaborate with Professor Bajaj and his group at the University of Texas to develop a general and much more theoretically rigorous algorithm for fitting the ligand binding region of experimental protein ligand cocrystal structures Current methods and practices often lead to very poor geometries for the bound ligand This is a significant impediment to the most effective use of crystallography in drug discovery We will solve this problem by developing an automated method for using polar sampling and optimization in conjunction with the experimental electron density information to correct protein ligand cocrystal structures This methodology will capitalize on recent advances in the Bajaj lab with respect to fast multidimensional optimization linear scaling electrostatics and solvation methods and advanced data structures for representing molecular systems This software has great commercial potential since the problem of properly fitting bound ligands has been receiving increasing attention in the literature and industry As such our solution will have
broad impact on structure based drug design

PUBLIC HEALTH RELEVANCE Gfree Bio will collaborate with Professor Bajajandapos s group at the University of Texas at Austin to develop a new method to solve the problem of ill defined ligand geometries in protein ligand cocrystal structures This program will provide significantly better starting points for structure based design of new drug candidates and contribute to academic and commercial efforts to develop new treatments for a range of diseases

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government